Bioresorbable stent (BRS) technology is not dead, but the unbridled enthusiasm seen two years ago for the technology has been replaced with a much more somber, cautiously optimistic tone at the...
Stents Drug Eluting
This channel includes news and new technology innovations for drug eluting stents (DES). This includes both metallic and bioresorbable drug-eluting stents and related clinical trial data.
-
-
Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific, explains...
-
A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific, on future directions for cardiology device technology...
-
Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application to market the Eluvia Drug-Eluting Vascular Stent System,...
Bioresorbable stents (BRS) in development, presented by Gregg Stone, M.D., during TCT 2017. Several of the players listed on the slider put their BRS development programs on hold after the negative data from the ABSORB III Trial, but a handful of smaller companies are still pushing the technology forward.
Feature | Stents Bioresorbable | October 12, 2018 | Dave Fornell, Editor
Bioresorbable stent (BRS) technology is not dead, but the unbridled enthusiasm seen two years ago for the technology...
Videos | October 11, 2018
A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president,...
The Biotronik Osiro is an ultra thin strut, sirolimus-eluting stent.
News | Stents | October 04, 2018
October 4, 2018 – Investigators unveiled clinical data from the independent BIONYX and SORT OUT IX all-comers trials...
News | Stents Drug Eluting | October 01, 2018
October 1, 2018 — Recent results from the BIONYX randomized clinical study showed the novel, thin-strutted, polymer-...
Technology | Stents Drug Eluting | October 01, 2018
October 1, 2018 — Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its...
News | Stents Drug Eluting | September 26, 2018
September 26, 2018 — Positive 12-month data from the late-breaking IMPERIAL trial was presented at the 2018...
Image courtesy of Hexacath
News | Stents Drug Eluting | May 31, 2018
May 31, 2018 – Late-breaking...
News | Stents Drug Eluting | May 31, 2018
May 31, 2018 — Two-year outcome data from the BIO-RESORT randomized controlled trial were presented in a late-...
News | Stents Bifurcation | May 29, 2018
May 29, 2018 – Medtronic plc announced the initiation of a U.S....
Technology | Stents Drug Eluting | May 25, 2018
May 25, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for Xience...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at the 2018...
Technology | Stents Drug Eluting | February 26, 2018
February 26, 2018 – Designed specifically for small vessels, Medtronic plc announced U.S. Food and Drug...
